Your shopping cart is currently empty

Omaciclovir (ABT-091) is a selective herpesvirus herpesvirus replication inhibitor and a nucleoside analog with antiviral activity for the study of herpesvirus infections.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $149 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | 10-14 weeks | 10-14 weeks |
| Description | Omaciclovir (ABT-091) is a selective herpesvirus herpesvirus replication inhibitor and a nucleoside analog with antiviral activity for the study of herpesvirus infections. |
| Targets&IC50 | MeWo VZ30:0.016 μM (EC50), MeWo VZ11:0.035 μM (EC50), MRC5 VZV-32:0.72 μM (EC50), MRC5 Molly:0.62 μM (EC50), MeWo Emily:0.047 μM (EC50), MeWo Molly:0.048 μM (EC50), MeWo VZV-32:0.015 μM (EC50) |
| In vitro | Omaciclovir is a nucleoside analog with inhibitory activity in vitro against varicella-zoster virus (VZV), herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), Epstein-Barr virus, and human herpesvirus 6. Additionally, Omaciclovir demonstrates significant antiviral activity against various human herpesviruses, with half-maximal effective concentrations (EC50) of EC50=0.72 μM, EC50=0.62 μM, EC50=0.015 μM, EC50=0.048 μM, EC50=0.047 μM, EC50=0.035 μM, and EC50=0.016 μM in MRC-5 VZV-32, MRC-5 Molly, MeWo VZV-32, MeWo Molly, MeWo Emily, MeWo VZ11, and MeWo VZ30, respectively. [1] |
| In vivo | Omaciclovir has also shown efficacy in monkeys infected with simian varicella virus. [1] |
| Synonyms | H2G, H 2G, ABT-091, ABT091, ABT 091, (-)-2HM-HBG |
| Molecular Weight | 253.26 |
| Formula | C10H15N5O3 |
| Cas No. | 124265-89-0 |
| Smiles | C([C@@H](CCO)CO)N1C2=C(N=C1)C(=O)N=C(N)N2 |
| Relative Density. | 1.68g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (789.7 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (19.74 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.